Pipeline Preview (August 2006)

News
Article

Hepatitis B immune globulin (human) (Nabi-HB, Nabi Bio-pharmaceuticals) for the treatment of hepatitis B infection

Recommendations for approval

Approvable designations

Fast-track designations

Orphan drug designations

Non-approvable designations

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.